Dermatology clinical trials recruiting in Illinois

32 recruiting dermatology trials match in Illinois. Showing 20.

• Study of Targeted Therapies for the Treatment of Adult Participants With Active Psoriatic ArthritisRecruiting

  Phase 2 · AbbVie · Skokie, Illinois

• Dose Ranging Study of ORKA-002 in Patients With Moderate-to-Severe Plaque PsoriasisRecruiting

  Phase 2 · Oruka Therapeutics, Inc. · Rolling Meadows, Illinois

• A Study to Evaluate the Efficacy and Safety of Icotrokinra (JNJ-77242113) in Biologic-experienced and Biologic-naive Participants With Active Psoriatic ArthritisRecruiting

  Phase 3 · Janssen Research & Development, LLC · Glendale, Arizona

• A Study of JNJ-95597528 in Participants With Moderate to Severe Atopic DermatitisRecruiting

  Phase 2 · Janssen Research & Development, LLC · São Paulo

• A Study to Learn if Bimekizumab Given in Different Ways is Safe and Moves Similarly Throughout the Body Over Time in AdultsRecruiting

  Phase 1 · UCB Biopharma SRL · Chicago, Illinois

• A Study to Investigate Effectiveness of Tirzepatide Following Initiation of Ixekizumab in Participants With Active Psoriatic Arthritis and Overweight or Obesity in Clinical Practice (TOGETHER AMPLIFY-PsA)Recruiting

  Phase 4 · Eli Lilly and Company · Chicago, Illinois

• A Study to Assess Adverse Events and Change in Disease Activity Comparing Oral Upadacitinib to Subcutaneous Dupilumab in Children From 2 to Less Than 12 Years of Age With Moderate to Severe Atopic DermatitisRecruiting

  Phase 3 · AbbVie · Chicago, Illinois

• A Dose-ranging Study to Evaluate the Efficacy, Safety, Pharmacokinetics, and Pharmacodynamics of Galvokimig in Adult Study Participants With Atopic DermatitisRecruiting

  Phase 2 · UCB Biopharma SRL · Chicago, Illinois

• A Study to Investigate Safety and Efficacy of Tapinarof Cream, 1% in Participants Ages 3 Months to < 24 Months With Atopic DermatitisRecruiting

  Phase 3 · Organon and Co · Skokie, Illinois

• A Study to Evaluate the Efficacy and Safety of JNJ-88545223 for the Treatment of Participants With Active Psoriatic ArthritisRecruiting

  Phase 2 · Janssen Research & Development, LLC · Willowbrook, Illinois

• Testing an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Cancers in Patients With Autoimmune Disorders, AIM-NIVORecruiting

  Phase 1 · National Cancer Institute (NCI) · Sacramento, California

• A Phase 2b Study of the Effects of Camoteskimab in Adults With Moderate-to-Severe Atopic DermatitisRecruiting

  Phase 2 · Apollo Therapeutics Ltd · Northridge, California

• A Study to Evaluate the Efficacy and Safety of IMG-007 in Adult Participants With Moderate-to-Severe Atopic DermatitisRecruiting

  Phase 2 · Inmagene LLC · Rolling Meadows, Illinois

• A Study to Evaluate the Safety and Efficacy of Ruxolitinib Cream in Pediatric Participants With Nonsegmental VitiligoRecruiting

  Phase 3 · Incyte Corporation · Chicago, Illinois

• Targeted Investigation of Microbiome 2 Treat Atopic Dermatitis (TIME-2)Recruiting

  Phase 1 · National Institute of Allergy and Infectious Diseases (NIAID) · Chicago, Illinois

• Study to Evaluate Safety, Efficacy and Immunogenicity of Acne mRNA Vaccine in Adults With Moderate to Severe AcneRecruiting

  Phase 1 / Phase 2 · Sanofi Pasteur, a Sanofi Company · Chicago, Illinois

• A Study of Upadacitinib in Adult Participants With Moderate-to-Severe Atopic Dermatitis and Inadequate Response to DupilumabRecruiting

  Phase 3 · AbbVie · Chicago, Illinois

• Using Dupilumab to Improve Circadian Function, Sleep and Pruritus in Children With Moderate/Severe Atopic DermatitisRecruiting

  Phase 4 · Northwestern University · Chicago, Illinois

• A Study to Evaluate the Efficacy and Safety of Subcutaneous Amlitelimab on Background Topical Corticosteroids Therapy in Participants Aged 12 Years and Older With Moderate-to-severe AD Who Have Had an Inadequate Response to Prior Biologic Therapy or an Oral JAK InhibitorRecruiting

  Phase 3 · Sanofi · Chicago, Illinois

• Dose Ranging Study of ORKA-001 in Patients With Moderate-to-Severe Plaque PsoriasisRecruiting

  Phase 2 · Oruka Therapeutics, Inc. · Rolling Meadows, Illinois

Source: ClinicalTrials.gov. Recruitment status changes often — confirm on each study page.